What happened
Spring 2026 brought a wave of "peptide complex" launches from major brands. Six, eight, and even twelve-peptide formulas now exist at every price tier. AI-personalized peptide subscriptions launched at the Sephora and Ulta level. Most formulas mix supplier-blended matrikines (Matrixyl, Matrixyl 3000, Matrixyl Synthe'6) with neuropeptides (Argireline-like), carrier peptides (GHK-Cu derivatives), and one or two "novelty" peptides used in single supplier studies.
Why it matters
- Peptides genuinely belong in a modern anti-aging routine. The matrikine families have moderate human evidence.
- Stacking 8 peptides doesn't multiply efficacy. Each peptide is at a low percentage; total active concentration matters more than label count.
- "AI-personalized" peptide picks are usually based on a selfie scoring system trained on limited diversity (see AI skin analysis).
- The peptide premium can stack absurdly fast — $80 serums become $180 serums for marginal additions.
What to watch next
- Independent head-to-head trials of multi-peptide formulas against single-peptide controls.
- Disclosure of supplier peptides as a percentage of total formula vs as their internal active concentration.
- EU regulators reviewing cosmetic claim language around peptides.
- Convergence with the exosome category — many "advanced regeneration" stacks now layer both.